GLP-1 receptor agonists and clinical outcomes in patients with type 2 diabetes undergoing transcatheter aortic valve implantation

Post time 3 day(s) ago

journal：European Heart Journal - Quality of Care and Clinical Outcomes

Authors：Hoang Nhat Pham; Ramzi Ibrahim; Mahmoud Abdelnabi; George Bcharah; Ahmed K Mahmoud; Mohamed Allam; Juan Farina; Justin Z Lee; Amitoj Singh; Chadi Ayoub; Said Alsidawi; Kristen A Sell-Dottin; Anwar Chahal; Dan Sorajja; Kwan Lee; Mohamad Alkhouli; Reza Arsanjani

Published date：2026-4-29

DOI：10.1093/ehjqcco/qcaf135

PDF link：https://academic.oup.com/ehjqcco ... 5220891/qcaf135.pdf

Article link：https://doi.org/10.1093/ehjqcco/qcaf135

Article Source：Oxford University Press (OUP)。

Remark：

Post time 3 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Oxford] GLP-1 receptor agonists and clinical outcomes in patients with type 2 diabetes undergoing transcatheter aortic valve implantation

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Oxford] GLP-1 receptor agonists and clinical outcomes in patients with type 2 diabetes undergoing transcatheter aortic valve implantation Copy